No Appeal of SK Court’s Refusal to Approve $20 Million Class Action Settlement

In May, we blogged about a recent decision of the Saskatchewan court in Perdikaris v. Purdue Pharma et al., 2018 SKQB 86 refusing approval of a $20 million class action settlement that had previously been approved in various other provinces. We noted that the defendants had sought leave to appeal the decision.

It now appears there will be no appellate consideration of the decision. In August, the defendants withdrew their application for leave to appeal. As a result, the Saskatchewan court’s refusal to approve the settlement stands.

Authors

Subscribe

Stay Connected

Get the latest posts from this blog

Please enter a valid email address